Rezolute Reports Full Year Fiscal 2023 Results and Highlights Company Progress
Planning to initiate Phase 3 Study for RZ358 in the fourth quarter of 2023REDWOOD CITY, Calif., Sept. 14, 2023 -- Rezolute, Inc. , a clinical-stage biopharmaceutical company dedicated to...